drugset / Trial / NCT04484779
A Study of an Insulin Management System in Participants With Type 1 or Type 2 Diabetes
NaSingle-groupOpen-labelDevice feasibility
Summary
The purpose of this study is to investigate the user experience of an integrated insulin management system (IIM) in participants with type 1 or type 2 diabetes. The IIM system is comprised of an insulin injection pen with a data transmission module and blood glucose meter which are connected to a mobile phone application. The application will be used to record and track diabetes-data related information.
Timeline
- Start
- 2020-07-14
- Primary completion
- 2020-12-22
- Completion
- 2020-12-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Insulin Lispro | Protein / enzyme biologic | — | Subcutaneous |
| Background | insulin glargine | Protein / enzyme biologic | — | Subcutaneous |